CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

erin-header4

CELL AND GENE LIVE

20_11_CG_CRISPRStemCellResearch_300X200_OD

 

CRISPR-engineered stem cell research has made tremendous advancements in the past five years, but challenges still exist. To overcome those challenges, industry experts, such as Sadik Kassim, CTO at Vor Biopharma, have dedicated their careers to the scale and manufacturing of CRISPR-engineered therapies.

Check out our discussion with Sadik on the benefits, the challenges and feasible solutions, what’s next, and more.

Cell & Gene Live On-Demand

CELL AND GENE CONTENT COLLECTIONS

20_10_CG_DesigningManufacturingProcess_Ebook_300x200

 

Ensuring scalability and efficient timelines in manufacturing while maintaining a reasonable cost is a major component of the cell and gene therapy sector in and of itself. Can the product be manufactured in the quantity and of the quality necessary to meet demand? Are your development protocols and timelines in order? Have you chosen the right facility, and have you invested in the best possible technology and equipment to ensure scalability? These are just some of the questions we answer for you in our collection of original editorial that caters to cell and gene therapy manufacturing processes.

More Content Collections

CELL & GENE INDUSTRY EVENTS